Qingdao Haier (China) Performance
| 688139 Stock | 33.20 0.19 0.57% |
Qingdao Haier has a performance score of 3 on a scale of 0 to 100. The company holds a Beta of -0.32, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Qingdao Haier are expected to decrease at a much lower rate. During the bear market, Qingdao Haier is likely to outperform the market. Qingdao Haier Biomedical right now holds a risk of 1.54%. Please check Qingdao Haier Biomedical downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Qingdao Haier Biomedical will be following its historical price patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Qingdao Haier Biomedical are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Qingdao Haier is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Forward Dividend Yield 0.0142 | Payout Ratio 0.5402 | Forward Dividend Rate 0.47 | Ex Dividend Date 2025-06-06 |
1 | 2025 - Futubull - | 09/16/2025 |
| Begin Period Cash Flow | 1.3 B |
Qingdao |
Qingdao Haier Relative Risk vs. Return Landscape
If you would invest 3,211 in Qingdao Haier Biomedical on July 22, 2025 and sell it today you would earn a total of 109.00 from holding Qingdao Haier Biomedical or generate 3.39% return on investment over 90 days. Qingdao Haier Biomedical is generating 0.0683% of daily returns and assumes 1.5421% volatility on return distribution over the 90 days horizon. Simply put, 13% of stocks are less volatile than Qingdao, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Qingdao Haier Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Qingdao Haier's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Qingdao Haier Biomedical, and traders can use it to determine the average amount a Qingdao Haier's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0443
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | 688139 | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.54 actual daily | 13 87% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Qingdao Haier is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Qingdao Haier by adding it to a well-diversified portfolio.
Qingdao Haier Fundamentals Growth
Qingdao Stock prices reflect investors' perceptions of the future prospects and financial health of Qingdao Haier, and Qingdao Haier fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Qingdao Stock performance.
| Return On Equity | 0.0638 | ||||
| Return On Asset | 0.0224 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 8.97 B | ||||
| Shares Outstanding | 317.95 M | ||||
| Price To Book | 2.41 X | ||||
| Price To Sales | 4.75 X | ||||
| Revenue | 2.28 B | ||||
| Gross Profit | 1.06 B | ||||
| EBITDA | 302.01 M | ||||
| Net Income | 366.63 M | ||||
| Total Debt | 10.01 M | ||||
| Book Value Per Share | 13.76 X | ||||
| Cash Flow From Operations | 291.67 M | ||||
| Earnings Per Share | 0.87 X | ||||
| Total Asset | 5.79 B | ||||
| Retained Earnings | 2.06 B | ||||
About Qingdao Haier Performance
By analyzing Qingdao Haier's fundamental ratios, stakeholders can gain valuable insights into Qingdao Haier's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Qingdao Haier has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Qingdao Haier has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Qingdao Haier is entity of China. It is traded as Stock on SHG exchange.Things to note about Qingdao Haier Biomedical performance evaluation
Checking the ongoing alerts about Qingdao Haier for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Qingdao Haier Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 41.0% of the company shares are owned by insiders or employees |
- Analyzing Qingdao Haier's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Qingdao Haier's stock is overvalued or undervalued compared to its peers.
- Examining Qingdao Haier's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Qingdao Haier's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Qingdao Haier's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Qingdao Haier's stock. These opinions can provide insight into Qingdao Haier's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Qingdao Stock analysis
When running Qingdao Haier's price analysis, check to measure Qingdao Haier's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Qingdao Haier is operating at the current time. Most of Qingdao Haier's value examination focuses on studying past and present price action to predict the probability of Qingdao Haier's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Qingdao Haier's price. Additionally, you may evaluate how the addition of Qingdao Haier to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Correlations Find global opportunities by holding instruments from different markets |